Partnering Strategy

  • Strategic partners – institutes, pharma, biotech – with innovative technology for the therapeutic
    areas that are of interest
  • Hospitals and organizations with strong specialization in targeted indications
  • Large pharma with a proven track record of strong clinical development
    and commercialization abilities
Areas of Interest

Therapeutic Areas

  • Oncology
  • Immuno-oncology
  • Autoimmune diseases


  • Small molecule drugs
  • Monoclonal antibodies
  • Peptide drugs
  • Diagnostic kits
  • Clinical biomarkers
  • Pharmacodiagnostics